greenRush.com Closes $3.6 Million Series A Funding Round

CALIFORNIA:  greenRush.com, the largest online marketplace for legally purchasing cannabis, today announced the $3.6 million closing of its Series A Funding Round. The Round will fuel the expansion of the company’s current recreational and medical marijuana services in California, Nevada, Massachusetts, Maryland, New York, Pennsylvania, and Illinois.

The company’s latest group of investors include James Weil, President of JMM Industries, and Chris Burggraeve, former Anheuser-Busch InBev Global Chief Marketing Officer. James Weil will be joining the greenRush Board of Directors and Chris Burggraeve will be joining the Advisory Board.

Rachel Shipp, greenRush.com Vice President of Business Development, said, “We are thrilled to welcome James Weil and Chris Burggraeve, along with a diverse network of notable venture capital, private equity, finance and marketing executives, to greenRush as investment and advisory partners.” Shipp continued, “We see an increasingly upward trend in institutional capital’s appetite and enthusiasm for investing in the Cannabis industry and our investors’ experience and guidance will help poise greenRush.com to successfully capitalize on those opportunities — now and in the future.”

Casa Verde Capital Leads Investment In Cannabis Testing Lab Cannalysis

Snoop Dogg Venture Firm Helps Analytical Cannabis Laboratory Expand Its Nationwide Footprint

CALIFORNIA: Cannalysis, a cannabis testing laboratory, announced today a seed investment led by Casa Verde Capital. As the premier cannabis testing lab in the market, Cannalysis harnesses technology to provide best-in-class service to some of the largest cultivators and brands in California.

With California’s adult-use regulations coming into effect next year, government-mandated third party testing will create a huge demand for services. However, many existing labs are not prepared to deal with this type of volume due to inferior technology, creating significant bottlenecks in getting clean product to market. As such, Cannalysis is poised to fill this gap, with industry leading, guaranteed three business-day turnarounds.

Having built a custom platform from the ground up, Cannalysis streamlines the testing experience and puts all data in the client’s hands, providing real-time tracking and sample status updates. Furthermore, beautiful and intuitive reporting enables Cannalysis to deliver the story behind the test results, something that customers genuinely appreciate.

In that vein, Kurvana, one of the largest cannabis brands in California had this to say on its relationship with Cannalysis. “They push our high volumes of samples through analysis without impact to quality or turnaround time, and they are willing to work with us to prioritize the results we need most. Placing value in collaboration and transparency, Cannalysis has exceeded our expectations and raised our standards.”

“With a tech-first approach, Cannalysis has quickly established itself as one of the leading lab platforms in California. This approach has also positioned Cannalysis to quickly scale and establish JV partners around the country,” said Karan Wadhera, managing partner at Casa Verde Capital. Mr. Wadhera continued, “in fact, the first Cannalysis JV will come online in Portland early next year and we’re eager to secure new partnerships across the country to help extend the Cannalysis brand.”

Brian Lannon, CEO of Cannalysis, echoed these remarks, saying “we are at an inflection point for this industry and we are ready to expand. Having a marquee investor and strategic partner like Casa Verde, will be instrumental in helping us achieve our growth objectives.”

Eaze Raises Additional $27 Million

CALIFORNIA: Cannabis technology companyEaze has announced an additional $27 million in Series B financing, led by Bailey Capital with participation from DCM Ventures, Kaya Ventures and FJ Labs.

The latest round brings Eaze’s total funding to $52 million. Eaze will use the financing for continued expansion throughout California and other states, to provide safe, convenient and professional access to legal marijuana. James Bailey has also joined the board of directors bringing relevant industry experience as an investor in PAX Labs, High Times and MedMen.

“An increasing number of Americans recognize that when used responsibly, marijuana can dramatically enhance their lives. Through our commitment to education, Eaze is playing a crucial role in the normalization of something that can unequivocally make lives better,” said Jim Patterson, CEO of Eaze. “With the legalization of adult use marijuana on the horizon, we look forward to using our data, technology and platform to continue to serve our mission of providing safe, secure access to marijuana products at the lowest prices with the utmost convenience.”

This announcement of additional capital comes at a time when Eaze has experienced rapid growth, seeing a 300% year-over-year increase in gross sales through its platform and now facilitating over 120,000 deliveries per month. Launched in 2014, Eaze connects customers through its mobile app or website to delivery drivers from local, legal and compliant dispensaries in most major California cities. For patients in need of a medical marijuana recommendation, EazeMD connects California residents with independent, board-certified doctors to receive an evaluation on demand.